Kapikian AZ, Chanock RM. Rotaviruses. In: Fields BN, Knipe DM, Howley PM, et al, eds. Fields Virology. 3rd ed. vol 2. New York; NY: Raven Press; 1996:1657-1708.
Estes MK. Rotaviruses and their replication. In: Fields BN, Knipe DM, Howley PM, et al, eds. Fields Virology. 3rd ed. Vol 2. New York, NY: Raven Press; 1996:1625-1655.
Institute of Medicine. The prospects of immunizing against rotavirus. In: New Vaccine Development: Diseases of Importance
in Developing Countries. Vol 2. Washington, DC: National Academy Press;
Parashar UD, Bresee JS, Gentsch JR, Glass, RI. Rotavirus. Emerg Infect Dis.1998;4:561-570.
Not Available. Rotavirus vaccine for the prevention of rotavirus gastroenteritis among
children: recommendations of the Advisory Committee on Immunization Practices
(ACIP). MMWR Recomm Rep.1999;48(RR-2):1-20.
Vesikari T, Kapikian AZ, Delem A, Zissis G. A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237)
oral rotavirus vaccines in young children. J Infect Dis.1986;153:832-839.
Gotherfors L, Wadell G, Juto P.
et al. Prolonged efficacy of rhesus rotavirus vaccine in Swedish children. J Infect Dis.1989;159:753-757.
LeBaron CW, Lew J, Glass RI, Weber JM, Ruiz-Palacios GM. Annual rotavirus epidemic patterns in North America: results of a 5-year
retrospective survey of 88 centers in Canada, Mexico, and the United States. JAMA.1990;264:983-988.
Vesikari T, Rautenen T, Varis T.
et al. Rhesus rotavirus candidate vaccine. AJDC.1990;144:285-289.
Velázquez FR, Matson DO, Calva JJ.
et al. Rotavirus infection in infants as protection against subsequent infections. N Engl J Med.1996;335:1022-1028.
Rennels MB, Glass RI, Dennehy PH.
et al. Safety and efficacy of high-dose rhesus-human reassortant rotavirus
vaccines: report of the National Multicenter Trial. Pediatrics.1996;97:7-13.
Perez-Schael I, Guntinas MJ, Perez M.
et al. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants
and young children in Venezuela. N Engl J Med.1997;337:1181-1187.
Joensuu J, Koskenniemi E, Pang XL, Vesikari T. A randomized, double-blind placebo controlled trial of rhesus-human
reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet.1997;350:1205-1209.
Rennels MB. The rotavirus vaccine story: a clinical investigator's view. Pediatrics.2000;106:123-125.
Offit PA. The rotavirus vaccine. J Clin Virol.1998;11:155-159.
Not Available. New oral rotavirus vaccine helps prevent severe childhood diarrhea
and vomiting [press release]. Rockville, Md: US Food and Drug Administration. August 31, 1998.
Available at: http://www.fda.gov/bbs/topics/NEWS/NEW00652.html.
Accessed May 8, 2001. Accessibility verified February 1, 2002.
American Academy of Pediatrics. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine. Pediatrics.1998;102:1483-1491.
Not Available. Intussusception among recipients of rotavirus vaccine B: United States,
1998-1999. MMWR Morb Mortal Wkly Rep.1999;48:577-581.
Zanardi LR, Haber P, Mootrey GT, Niu MT, Wharton M.and the VAERS Working Group. Intussusception among recipients of rotavirus vaccine: reports to the
Vaccine Adverse Reporting System. Pediatrics.2001;107:e97. Available at: http://www.pediatrics.org/cgi/content/full/107/6/e97. Accessed July 18, 2001. Accessibility verified February 12, 2002.
American Home Products Corporation. AHP news 1998,1999. Available at: http://www.ahp.com/news/index.asp. Accessed
May 8, 2001. Accessibility verified February 1, 2002.
Murphy TV, Gargiullo PM, Massoudi MS.
et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med.2001;344:564-572.
Kramarz P, France EK, Destefano F.
et al. Population-based study of rotavirus vaccination and intussusception. Pediatr Infect Dis J.2001;20:410-416.
Not Available. Withdrawal of rotavirus vaccine recommendation. MMWR Morb Mortal Wkly Rep.1999;48:1007.
Chen RT, DeStefano F. Vaccine safety. Lancet.1998;352:63-64.
Kane MA. Commentary: public perception and the safety of immunization. Vaccine.1998;16:S73-S75.
Chen RT. Safety of vaccines. In: Plotkin SA, Orenstein WA, eds. Vaccines.
3rd ed. Philadelphia, Pa: WB Saunders Co; 1998:1144-1163.
Sansom SL, Barker L, Corso P, Brown C, Deuson R. Rotavirus vaccine and intussusception: how much risk will parents in
the United States accept to obtain vaccine benefits. Am J Epidemiol.2001;154:1077-1085.
Not Available. Americans Talk About Science and Medical News: The
National Health Council Report: Prepared for the National Health Council. New York, NY: Roper Starch Worldwide; 1997.
Gellert GA, Higgins KV, Lowery RM, Maxwell RM. A national survey of public health officers' interactions with the
Nelkin D. Managing biomedical news. Social Res.1985;52:625-646.
Singer E, Endreny P. Reporting hazards: their benefits and costs. J Communication.1987;37:10-26.
Not Available. AAP vaccine information addresses parents' concerns: periodic survey. AAP News.January 2001:6.
Frost K, Frank E, Maibach E. Relative risk in the news media: a quantification of misrepresentation. Am J Public Health.1997;87:842-845.
Moynihan R, Bero L, Ross-Degnan D.
et al. Coverage by the news media of the benefits and risks of medications. N Engl J Med.2000;342:1645-1650.
Freed GL, Katz SL, Clark SJ. Safety of vaccinations: Miss America, the media, and public health. JAMA.1996;276:1869-1872.
Cohn V. Vaccines and risks: the responsibility of the media, scientists, and
clinicians [editorial]. JAMA.1996;276:1917-1918.
Leask JA, Chapman S. An attempt to swindle nature: press anti-immunisation reportage, 1993-1997. Aust N Z J Public Health.1998;22:17-26.
Mason BW, Donnelly PD. Impact of a local newspaper campaign on the uptake of the measles mumps
and rubella vaccine. J Epidemiol Community Health.2000;54:473-474.
Jefferson T. Real or perceived adverse effects of vaccines and the media: a tale
of our times [editorial]. J Epidemiol Community Health.2000;54:402-403.
Griffith AH. Medicine and the media: vaccination against whooping cough. J Biol Standard.1981;9:475-482.
Harding CM. Whooping cough vaccination: the case presented by the British national
press. Child Care Health Dev.1985;11:21-30.
Gangarosa EJ, Galazka AM, Wolfe CR.
et al. Impact of anti-vaccine movements on pertussis control: the untold story. Lancet.1998;351:356-361.
Feudtner C, Marcuse EK. Ethics and immunization policy: promoting dialogue to sustain consensus. Pediatrics.2001;107:1158-1164.
America Journalism Review. News Link [database]. Available at: http://ajr.newslink.org. Accessed July 24,
2000. Accessibility verified February 1, 2002.
Audit Bureau of Circulation. National circulation data based on region. Available at: http://www.auditbureau.org. Accessed January
Mass Media Bureau. Radio and television call letters. Mass Media Bureau, Federal Communications Commission. Available at: http://www.fcc.gov/mmb. Accessed March 3, 2001.
Landis JR, Koch GG. An application of hierarchical kappa-type statistics in the assessment
of majority agreement among multiple observers. Biometrics.1977;33:363-374.
Not Available. Thimerosal in vaccines: a joint statement of the American Academy of
Pediatrics and the Public Health Service. MMWR Morb Mortal Wkly Rep.1999;48:563-565.
Not Available. Availability of hepatitis B vaccine that does not contain thimerosal
as a preservative. MMWR Morb Mortal Wkly Rep.1999;48:780-782.
US Environmental Protection Agency. Mercury Study Report to Congress, V: Health Effects
of Mercury and Mercury Compounds. Research Triangle Park, NC: US Environmental Protection Agency, Office
of Air Quality Planning and Standards and Office of Research and Development;
December 1997. EPA-452/R-97-007.
Halsey NA. Limiting infant exposure to thimerosal in vaccines and other sources
of mercury. JAMA.1999;282:1763-1766.
Hibbs B, Ndiaye S, Scott S, Stewart M. What calls to the national immunization hotline reveal about perceived
health risks. In: Program and abstracts of the Society for Risk Analysis Annual
Meeting; December 5-8, 1999; Atlanta, Ga. Abstract. w19.02.
RotaShield, Rotavirus Vaccine Sponsor Presentation. Dept of Health
and Human Services, US Food and Drug Administration, Center for Biologics
Evaluation and Research Vaccines and Related Biological Products Advisory
Committee. Bethesda, Md: US Food and Drug Administration; December 12, 1997. Available at: http://www.fda.gov/ohrms/dockets/ac/cber97t.htm. Accessibility verified February 12, 2002.
Centers for Disease Control and Prevention Advisory Committee on Immunization Practice. Records of the Meeting Held on June 16-17, 1999; Atlanta, Ga.
Rennels MB, Parashar UD, Holman RC, Le CT, Chang HG, Glass RI. Lack of an apparent association between intussusception and wild or
vaccine rotavirus infection. Pediatr Infect Dis J.1998;17:924-925.
Howson CP, Howe CJ, Fineberg HV. Adverse Effects of Pertussis and Rubella Vaccines:
A Report to the Committee to Review the Adverse Consequences of Pertussis
and Rubella Vaccines. Washington, DC: National Academy Press; 1991.
Brown F, Greco D, Mastrantonio P, Salmaso S, Wassilak S. Pertussis Vaccine Trials: Istituto Superiore di Sanità,
Italy, October 30-November 1, 1995. Basel, NY: Karger; 1997. Developments in Biological Standarization
Series; Vol 89.
Farrington P, Pugh S, Colville A.
et al. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis
and measles/mumps/rubella vaccines. Lancet.1995;345:567-569.
Not Available. Update: Vaccine side effects adverse reactions, contraindications,
and precautions: recommendations of the Advisory Committee on Immunization
Practices (ACIP). MMWR Recomm Rep.1996;45(RR-12):1-35.
Miller E, Waight P, Farrington P, Andrews N, Stowe J, Taylor B. Idiopathic thrombocytopenic purpura and MMR vaccine. Arch Dis Child.2001;84:227-229.
Ad Hoc Group for the study of Pertussis vaccines. Placebo-controlled trial of two acellular Pertussis vaccines in Sweden:
Protective efficacy and Adverse events. Lancet.1998;1:955-960.
DuVernoy TS, Braun MM.and the VAERS Working Group. Hypotonic-hyporesponsive episodes reported to the Vaccine Adverse Event Reporting System (VAERS), 1996-1998. Pediatrics.2000;106:E52.
Pokorny WJ. Intussusception. In: Oski FA, DeAngelis C, Feigin RD, McMillan JA, Warshaw JB, eds.
Principles and Practice of Pediatrics. 2nd ed. Philadelphia, Pa: JB Lippincott Co; 1994:1856-1858.
Daneman A, Alton DJ, Lobo E, Gravett J, Kim P, Ein SH. Patterns of recurrence of intussusception in children: a 17-year review. Pediatr Radiol.1998;28:913-919.
Gregorio L, Sutton CL, Lee DA. Central pontine myelinolysis in a previously healthy 4-year-old child
with acute rotavirus gastroenteritis. Pediatrics.1997;99:738-743.
Not Available. National, state, and urban area vaccination coverage levels among children
aged 19-35 months: United States, 1999. MMWR Morb Mortal Wkly Rep.2000;49:585-589.
Not Available. National, state, and urban area vaccination coverage levels among children
aged 19-35 months: United States, 2000. MMWR Morb Mortal Wkly Rep.2001;50:637-641.
Izenberg N, Lieberman DA. The Web, communication trends, and children's health, III: the Web
and health consumers. Clin Pediatr.1998;37:275-285.
Nasir L. Reconnoitering the antivaccination Web sites: news from the front. J Fam Pract.2000;49:731-733.
de-Semir V, Ribas C, Revuelta G. Press releases of science journal articles and subsequent newspaper
stories on the same topic. JAMA.1998;280:294-295.
Girardi E, Petrosillo N, Aloisi MS, Rava L, Ippolito G. Peer-reviewed articles and public health: the mad cow affair in Italian